These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9034167)

  • 1. Imprinted genes in liver carcinogenesis.
    De Souza AT; Yamada T; Mills JJ; Jirtle RL
    FASEB J; 1997 Jan; 11(1):60-7. PubMed ID: 9034167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors.
    Mills JJ; Falls JG; De Souza AT; Jirtle RL
    Oncogene; 1998 May; 16(21):2797-802. PubMed ID: 9652747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
    De Souza AT; Hankins GR; Washington MK; Orton TC; Jirtle RL
    Nat Genet; 1995 Dec; 11(4):447-9. PubMed ID: 7493029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imprint status of M6P/IGF2R and IGF2 in chickens.
    Nolan CM; Killian JK; Petitte JN; Jirtle RL
    Dev Genes Evol; 2001 Apr; 211(4):179-83. PubMed ID: 11455432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
    Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
    Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal transmission of an Igf2r domain 11: IGF2 binding mutant allele (Igf2r
    Hughes J; Surakhy M; Can S; Ducker M; Davies N; Szele F; Bühnemann C; Carter E; Trikin R; Crump MP; Frago S; Hassan AB
    Sci Rep; 2019 Aug; 9(1):11388. PubMed ID: 31388182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) in carcinogenesis.
    Martin-Kleiner I; Gall Troselj K
    Cancer Lett; 2010 Mar; 289(1):11-22. PubMed ID: 19646808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan.
    Oka Y; Waterland RA; Killian JK; Nolan CM; Jang HS; Tohara K; Sakaguchi S; Yao T; Iwashita A; Yata Y; Takahara T; Sato S; Suzuki K; Masuda T; Jirtle RL
    Hepatology; 2002 May; 35(5):1153-63. PubMed ID: 11981765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary.
    Killian JK; Nolan CM; Wylie AA; Li T; Vu TH; Hoffman AR; Jirtle RL
    Hum Mol Genet; 2001 Aug; 10(17):1721-8. PubMed ID: 11532981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M6P/IGF2 receptor: a candidate breast tumor suppressor gene.
    Hankins GR; De Souza AT; Bentley RC; Patel MR; Marks JR; Iglehart JD; Jirtle RL
    Oncogene; 1996 May; 12(9):2003-9. PubMed ID: 8649861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M6P/IGF2R imprinting evolution in mammals.
    Killian JK; Byrd JC; Jirtle JV; Munday BL; Stoskopf MK; MacDonald RG; Jirtle RL
    Mol Cell; 2000 Apr; 5(4):707-16. PubMed ID: 10882106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?
    DaCosta SA; Schumaker LM; Ellis MJ
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):85-94. PubMed ID: 10791771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific inactivation of murine M6P/IGF2R.
    Wylie AA; Pulford DJ; McVie-Wylie AJ; Waterland RA; Evans HK; Chen YT; Nolan CM; Orton TC; Jirtle RL
    Am J Pathol; 2003 Jan; 162(1):321-8. PubMed ID: 12507915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution.
    Williams C; Hoppe HJ; Rezgui D; Strickland M; Forbes BE; Grutzner F; Frago S; Ellis RZ; Wattana-Amorn P; Prince SN; Zaccheo OJ; Nolan CM; Mungall AJ; Jones EY; Crump MP; Hassan AB
    Science; 2012 Nov; 338(6111):1209-13. PubMed ID: 23197533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotreme IGF2 expression and ancestral origin of genomic imprinting.
    Killian JK; Nolan CM; Stewart N; Munday BL; Andersen NA; Nicol S; Jirtle RL
    J Exp Zool; 2001 Aug; 291(2):205-12. PubMed ID: 11479919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
    Vu TH; Yballe C; Boonyanit S; Hoffman AR
    J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.
    Killian JK; Oka Y; Jang HS; Fu X; Waterland RA; Sohda T; Sakaguchi S; Jirtle RL
    Hum Mutat; 2001; 18(1):25-31. PubMed ID: 11438990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
    Chen Z; Ge Y; Landman N; Kang JX
    BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.